HABP2
Factor VII-activating protease
Also known as: FSAP, HABP, HABP2_HUMAN, HGFAL, PHBP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14520
- Gene
- HABP2
- Ensembl
- ENSG00000148702
- Chromosome
- 10
- Canonical length
- 560 aa
- Protein class
- Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is secreted by hepatocytes and proteolytically processed to generate heavy and light chains that form the mature heterodimer. Further autoproteolysis leads to smaller, inactive peptides. This extracellular protease binds hyaluronic acid and may play a role in the coagulation and fibrinolysis systems. Mutations in this gene are associated with nonmedullary thyroid cancer and susceptibility to venous thromboembolism. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
560 residues, UniProt reviewed canonical sequence.
>Q14520|HABP2
1 MFARMSDLHV LLLMALVGKT ACGFSLMSLL ESLDPDWTPD QYDYSYEDYN QEENTSSTLT
61 HAENPDWYYT EDQADPCQPN PCEHGGDCLV HGSTFTCSCL APFSGNKCQK VQNTCKDNPC
121 GRGQCLITQS PPYYRCVCKH PYTGPSCSQV VPVCRPNPCQ NGATCSRHKR RSKFTCACPD
181 QFKGKFCEIG SDDCYVGDGY SYRGKMNRTV NQHACLYWNS HLLLQENYNM FMEDAETHGI
241 GEHNFCRNPD ADEKPWCFIK VTNDKVKWEY CDVSACSAQD VAYPEESPTE PSTKLPGFDS
301 CGKTEIAERK IKRIYGGFKS TAGKHPWQAS LQSSLPLTIS MPQGHFCGGA LIHPCWVLTA
361 AHCTDIKTRH LKVVLGDQDL KKEEFHEQSF RVEKIFKYSH YNERDEIPHN DIALLKLKPV
421 DGHCALESKY VKTVCLPDGS FPSGSECHIS GWGVTETGKG SRQLLDAKVK LIANTLCNSR
481 QLYDHMIDDS MICAGNLQKP GQDTCQGDSG GPLTCEKDGT YYVYGIVSWG LECGKRPGVY
541 TQVTKFLNWI KATIKSESGFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HABP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 409 nTPM
Expression across tissuesHPA
Tissue
- liver: 409 nTPM
- gallbladder: 34 nTPM
- pancreas: 16 nTPM
- kidney: 14 nTPM
- stomach: 11 nTPM
- heart muscle: 4 nTPM
Single-cell type
- hepatocytes: 247 nCPM
- cholangiocytes: 120 nCPM
- oocytes: 83 nCPM
- cardiomyocytes: 81 nCPM
- pancreatic duct cells: 43 nCPM
- gastric chief cells: 27 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 2.3 nTPM
- white matter: 1.1 nTPM
- basal ganglia: 0.4 nTPM
- thalamus: 0.4 nTPM
- hippocampal formation: 0.3 nTPM
- amygdala: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HABP2.
Disease | AllUniProt
Conditions HABP2 is implicated in, by any mechanism.
- Thyroid cancer, non-medullary, 5 (NMTC5) MIM:616535
Disease | ImmuneIEDB
Conditions an epitope on HABP2 was assayed in.
- rheumatoid arthritis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.2
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.43
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Kringle
- EGF-like domain
- Serine proteases, trypsin domain
- Peptidase S1A, chymotrypsin family
- EGF-like calcium-binding domain
- Peptidase S1, PA clan
- Kringle-like fold
- Kringle, conserved site
- Serine proteases, trypsin family, histidine active site
- Serine proteases, trypsin family, serine active site
- Kringle superfamily
- Serine Proteases (Peptidase S1 Family)
- EGF-like domain
- Kringle domain
- Trypsin
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HABP2 as an antibody target. Whether an autoantibody or antibody against HABP2 could matter depends on whether native HABP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HABP2 is annotated as secreted, so native HABP2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label HABP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...